APA (7th ed.) Citation

Wu, Y. S., Burger, E. A., Holmboe, F., Bangum, M., Oteiza, F., Bugge, C., . . . Aas, E. (2026). Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer. PharmacoEconomics - Open, 10(4), 679. https://doi.org/10.1007/s41669-026-00656-9

Chicago Style (17th ed.) Citation

Wu, Yancy S., Emily A. Burger, Fredrik Holmboe, Magnus Bangum, Francisco Oteiza, Christoffer Bugge, Erik Magnus Sæther, and Eline Aas. "Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer." PharmacoEconomics - Open 10, no. 4 (2026): 679. https://doi.org/10.1007/s41669-026-00656-9.

MLA (9th ed.) Citation

Wu, Yancy S., et al. "Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer." PharmacoEconomics - Open, vol. 10, no. 4, 2026, p. 679, https://doi.org/10.1007/s41669-026-00656-9.